Skip to main content

Shared from the PPN World agenda

CHSwitzerlandEarnings

Novartis third-quarter 2026 results, Basel

Novartis reports Q3 from Basel with a media and analyst briefing. Growth-driver sales and the response to looming US patent expiries are the story, and the print typically sets the tone for European pharma that week.

News
3/5
Markets
3/5
Overall
3/5
XLinkedInWhatsAppFacebook

Also on Tue, Oct 27

The whole day →The whole week →

Know what's coming. Read it the second it lands.

PPN World puts the world's scheduled set pieces — central banks, data, elections, summits — beside every press release from 1,400+ feeds in 190+ countries, live. Filter by country, export to your calendar, get alerted.

Cancel anytime · CA$99/month

Open the agenda in PPN World →About the World Agenda →

Shared via PPN World — real-time press release intelligence.